Review finds limited evidence for vaginal laser in breast cancer survivors
A scoping review examined vaginal fractional CO₂ laser therapy for genitourinary syndrome of menopause, a group of vaginal and urinary symptoms, among women with current or previous breast cancer. Across 22 reports involving approximately 1,099 participant observations, observational studies often reported symptom improvements, but two sham-controlled randomized trials did not find a clinically meaningful benefit over sham treatment. The findings are informational and do not establish whether this therapy is effective or safe over the long term.

